Epidemiological characteristics of breakthrough mumps infection cases from 2019 to 2023 in Chongqing, China

Yang Liu,Xiaoya Cai,Deming Yang,Yu Xiang,Qing Wang,Ning Yao,Yuanyuan Zhang,Jiawei Xu
DOI: https://doi.org/10.1080/21645515.2024.2426273
2024-11-19
Human Vaccines & Immunotherapeutics
Abstract:The high coverage of mumps-containing vaccine (MuCV) has effectively controlled the mumps incidence, while the prevention and control of breakthrough cases has become a prominent problem. To analyze the epidemiology of mumps breakthrough cases in Chongqing from 2019 to 2023, and provide scientific evidence for the prevention and control of mumps. The data of clinical and laboratory-confirmed mumps cases in Chongqing from 2019 to 2023 were exported from the China Information System for Disease Control and Prevention. The immunization history was screened and matched from the Chongqing Immunization Program Information System. Least-Significant Difference (LSD) and T-test were used for data analysis. There were 12,566 breakthrough cases in Chongqing, accounting for 61.09% of the total mumps cases reported. The most breakthrough infection occurred in the 3–9 years age group. In 2019 and 2020, the mean age of breakthrough cases with two doses was older than that with one dose ( p < .05). In 2022 and 2023, the age was younger than that with one dose ( p < .05). The breakthrough intervals for one dose and two doses were (4.87 ± 2.57) and (2.01 ± 1.79) years, respectively. The proportion of breakthrough mumps cases continues to increase in highly vaccinated populations in Chongqing. It is necessary to carry out research on a supplementary dose of MuCV vaccination strategy, and enhance the monitoring of mumps outbreaks in key populations such as children in kindergartens and primary schools. Mumps is a contagious viral infection caused by the mumps virus. There has been a sharp decrease in mumps cases in China due to immunization with mumps-containing vaccine (MuCV). However, some fully vaccinated people may still get mumps. To analyze the epidemiological characteristics of mumps breakthrough cases in Chongqing from 2019 to 2023, and provide scientific evidence for further prevention and control. Mumps cases were sourced from the national disease reporting system, and their vaccination history was collected from an authorized immunization system. Data were analyzed using appropriate methods. A total of 12,566 breakthrough cases were reported, with the majority occurring in the 3–9 age group. The age of onset of breakthrough cases that occurred after receiving two doses of MuCV in 2019 and 2020 was older than after receiving one dose. The results for 2022 and 2023 were exactly the opposite. Breakthrough cases of mumps in Chongqing have increased year by year, because vaccine protection may go down over time, but they usually have milder symptoms and fewer complications. The vaccination strategy of the third dose should be taken into account in time, and the monitoring of mumps outbreaks in key populations such as children in kindergartens and primary schools needs to be enhanced.
immunology,biotechnology & applied microbiology
What problem does this paper attempt to address?